ENFERMEDADES HEPÁTICAS
![Foto de ENFERMEDADES HEPÁTICAS](/img/grupo.png)
![Foto de Hannover Medical School](/img/noimage_org.png)
Hannover Medical School
Hanóver, AlemaniaPublikationen in Zusammenarbeit mit Forschern von Hannover Medical School (12)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe
Hepatology Communications, Vol. 7, Núm. 10
2022
-
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121
-
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966
-
Global multi-stakeholder endorsement of the MAFLD definition
The Lancet Gastroenterology and Hepatology
2021
-
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancer (British Journal of Cancer, (2020), 123, 7, (1047-1059), 10.1038/s41416-020-0987-3)
British Journal of Cancer
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
-
Next-generation biomarkers for cholangiocarcinoma
Cancers, Vol. 13, Núm. 13
2020
-
Current and novel therapeutic opportunities for systemic therapy in biliary cancer
British Journal of Cancer, Vol. 123, Núm. 7, pp. 1047-1059
2019
-
The challenges of primary biliary cholangitis: What is new and what needs to be done
Journal of Autoimmunity, Vol. 105